Interestingly, Carvallo had experience with ivermectin as an antiviral before the COVID outbreak. Argentinian doctors were using it against dengue fever, which is endemic in Argentina. So, when SARS-CoV-2 emerged, they decided to take another look at the drug to see if it might be useful.
“We came across some studies that were being conducted in Australia at the Monash University by people like Dr. Kylie Wagstaff,” Carvallo says. “We supposed that it would be very useful because the virology in effect already proved that, and we decided — even before they published their first findings — to replicate what they were doing, but in vivo. That is, not in the laboratory but in human beings.”
In early April 2020, Carvallo and his team developed two trials submitted to the National Library of Medicine in the United States. One was for preexposure1 (prevention) and the other for treatment. In both cases, ivermectin was used as an adjunct to other compounds, as they didn’t believe it was a silver bullet by itself.
For preventive purposes, they used ivermectin together with carrageenan, a food emulsifier and thickener that has a long history of use in both food and medicine. According to Carvallo, carrageenan has antiviral effects too, so the ivermectin was used in combination with topical carrageenan, administered through the nose and mucus membranes of the mouth.
In the treatment trial, ivermectin was combined with aspirin for mild cases, aspirin and corticosteroids for moderately severe cases, and enoxaparin (an anticoagulant drug) for severe cases.
These drug combinations were selected based on what was known about other viruses that cause similar health effects as SARS-CoV-2, such as the rhabdovirus’ effect on neurology, the paramyxovirus, which causes hyperinflammation in the lungs, and the dengue virus, which overamplifies the immune system.
There are good drugs to treat Covid with, but the want you to get the jab instead or just go ahead and die, especially with the jab. That’s their goal . Depopulation.